PRTKUnknown

Paratek Pharmaceuticals, Inc. Insider Trading Activity

Every SEC Form 4 insider transaction reported for Paratek Pharmaceuticals, Inc. (PRTK), sourced directly from SEC EDGAR and updated as new filings are accepted.

Last updated:

Quick Answer

Are PRTK insiders buying or selling?

Paratek Pharmaceuticals, Inc. insiders reported 1 open-market buys ($1.3M) and 89 sells ($7.0M) across 90 Form 4 filings — a net selling position of $5.7M.

Source: SEC EDGAR Form 4

Key Statistics (as of Aug 11, 2023)

Total Form 4 filings
90
SEC EDGAR
Insider filers
11
Insider buys (1)
$1.3M
Insider sells (89)
$7.0M

Insider sentiment

Net selling

Net insider flow of $5.7M in net selling.

Recent PRTK insider transactions

DateInsiderRoleTypeSharesPriceValue
Aug 11, 2023Randall B. BrennerChief Development & RegulatorySale27.6K$2.20$60.7K
Aug 11, 2023Michael BighamExec. Chairman of the BoardSale31.3K$2.20$68.8K
Aug 11, 2023William M. HaskelCLO, General Counsel & Sec.Sale34.5K$2.20$76.0K
Aug 11, 2023Evan LohCEOSale49.0K$2.20$107.7K
Mar 29, 2023DONDERO JAMES D10% OwnerPurchase788.5K$1.63$1.3M
Feb 23, 2023Jeffrey SteinDirectorSale7.0K$1.90$13.3K
Feb 23, 2023Timothy R FransonDirectorSale7.0K$1.88$13.2K
Dec 22, 2022Adam WoodrowPresident & Chief CommercialSale6.8K$1.99$13.4K
Dec 22, 2022Evan LohCEOSale23.5K$1.99$46.7K
Dec 22, 2022William M. HaskelCLO, General Counsel & Sec.Sale7.0K$1.99$13.9K
Dec 22, 2022Randall B. BrennerChief Development & RegulatorySale4.5K$1.99$9.0K
Dec 22, 2022Michael BighamExec. Chairman of the BoardSale15.8K$1.99$31.3K
Dec 15, 2022Adam WoodrowPresident & Chief CommercialSale10.1K$1.97$19.8K
Dec 15, 2022Evan LohCEOSale99.8K$1.97$196.3K
Dec 15, 2022William M. HaskelCLO, General Counsel & Sec.Sale38.0K$1.97$74.8K
Dec 15, 2022Randall B. BrennerChief Development & RegulatorySale29.3K$1.97$57.6K
Dec 15, 2022Michael BighamExec. Chairman of the BoardSale51.4K$1.97$101.1K
Nov 2, 2022Adam WoodrowPresident & Chief CommercialSale4.6K$3.47$15.8K
Nov 1, 2022Evan LohCEOSale8.8K$3.47$30.6K
Nov 1, 2022William M. HaskelCLO, General Counsel & Sec.Sale4.4K$3.47$15.2K
Nov 1, 2022Randall B. BrennerChief Development & RegulatorySale3.5K$3.47$12.2K
Nov 1, 2022Michael BighamExec. Chairman of the BoardSale6.0K$3.47$20.8K
Aug 11, 2022Evan LohCEOSale44.5K$2.66$118.4K
Aug 11, 2022William M. HaskelCLO, General Counsel & Sec.Sale22.5K$2.66$59.7K
Aug 11, 2022Randall B. BrennerChief Development & RegulatorySale19.6K$2.66$52.2K

Showing the 25 most recent of 90 Form 4 filings for Paratek Pharmaceuticals, Inc..

Most active PRTK insiders

  • Evan Loh18 filings
  • William M. Haskel17 filings
  • Adam Woodrow15 filings
  • Michael Bigham15 filings
  • Randall B. Brenner14 filings

Ask anything about PRTK insider activity

Use Trabud's AI agent to query Paratek Pharmaceuticals, Inc.'s Form 4 history in plain English — "Show me PRTK CEO purchases this year" or compare it against any other ticker.

Open the AI agent

PRTK insider trading FAQ

Are Paratek Pharmaceuticals, Inc. insiders buying or selling?

Across 90 SEC Form 4 filings, Paratek Pharmaceuticals, Inc. (PRTK) insiders reported 1 open-market purchases totaling $1.3M and 89 sales totaling $7.0M. That is a net selling position of $5.7M.

How many insiders trade PRTK stock?

11 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for Paratek Pharmaceuticals, Inc.. The most recent filing was accepted on Aug 11, 2023.

Where does Trabud get PRTK insider trading data?

All PRTK insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.

Looking for another company? Browse all tracked companies.

Related Content